Xizi Jiang

504 total citations
26 papers, 305 citations indexed

About

Xizi Jiang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xizi Jiang has authored 26 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Xizi Jiang's work include RNA modifications and cancer (8 papers), Plant Virus Research Studies (5 papers) and Epigenetics and DNA Methylation (4 papers). Xizi Jiang is often cited by papers focused on RNA modifications and cancer (8 papers), Plant Virus Research Studies (5 papers) and Epigenetics and DNA Methylation (4 papers). Xizi Jiang collaborates with scholars based in China. Xizi Jiang's co-authors include Xueshan Qiu, Hongbo Su, Hongjiu Ren, Yitong Xu, Jun Jiang, Yao Zhang, Xiaodan Sun, Lihong Jiang, Xin Song and Yizhuo Li and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Virology.

In The Last Decade

Xizi Jiang

26 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xizi Jiang China 12 180 85 59 50 37 26 305
Ali Dadbin United States 8 192 1.1× 73 0.9× 98 1.7× 44 0.9× 24 0.6× 10 355
Weihua Li China 11 196 1.1× 85 1.0× 57 1.0× 36 0.7× 23 0.6× 16 318
Zied Djabari France 7 203 1.1× 57 0.7× 42 0.7× 28 0.6× 13 0.4× 7 262
Suzanne B.R. Jacobs United States 9 312 1.7× 69 0.8× 60 1.0× 17 0.3× 66 1.8× 11 476
Bing Yu China 10 231 1.3× 57 0.7× 94 1.6× 30 0.6× 36 1.0× 17 341
Juan Zou China 13 241 1.3× 147 1.7× 70 1.2× 75 1.5× 46 1.2× 36 416
Jingyi Han China 11 232 1.3× 141 1.7× 64 1.1× 61 1.2× 57 1.5× 18 373

Countries citing papers authored by Xizi Jiang

Since Specialization
Citations

This map shows the geographic impact of Xizi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xizi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xizi Jiang more than expected).

Fields of papers citing papers by Xizi Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xizi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xizi Jiang. The network helps show where Xizi Jiang may publish in the future.

Co-authorship network of co-authors of Xizi Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xizi Jiang. A scholar is included among the top collaborators of Xizi Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xizi Jiang. Xizi Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Ma, Yue, Yao Zhang, Xizi Jiang, et al.. (2024). KIFC3 promotes the proliferation, migration and invasion of non-small cell lung cancer through the PI3K/AKT signaling pathway. Scientific Reports. 14(1). 20471–20471. 3 indexed citations
4.
Jiang, Siyu, Yizhuo Li, Xizi Jiang, et al.. (2023). RUNX1 promotes proliferation and migration in non‐small cell lung cancer cell lines via the mTOR pathway. The FASEB Journal. 37(11). 2 indexed citations
5.
Huang, Ying, Xizi Jiang, Hui Xu, et al.. (2022). Preoperative prediction of mediastinal lymph node metastasis in non-small cell lung cancer based on 18F-FDG PET/CT radiomics. Clinical Radiology. 78(1). 8–17. 12 indexed citations
6.
Zhao, Qingqing, Xizi Jiang, Zhanqi Wang, et al.. (2022). Strawberry vein banding virus-based vector for transient overexpression in strawberry plants. Phytopathology Research. 4(1). 2 indexed citations
7.
Jiang, Xizi, Wenhui Zhao, Yizhuo Li, et al.. (2022). Autophagy inhibition and reactive oxygen species elimination by acetyl-CoA acetyltransferase 1 through fused in sarcoma protein to promote prostate cancer. BMC Cancer. 22(1). 1313–1313. 3 indexed citations
8.
Zhao, Mengnan, Xizi Jiang, Yao Zhang, et al.. (2022). Upregulation of KLHL17 promotes the proliferation and migration of non-small cell lung cancer by activating the Ras/MAPK signaling pathway. Laboratory Investigation. 102(12). 1389–1399. 14 indexed citations
9.
Xu, Yitong, Chenglong Wang, Xizi Jiang, et al.. (2021). KLHL38 involvement in non-small cell lung cancer progression via activation of the Akt signaling pathway. Cell Death and Disease. 12(6). 556–556. 9 indexed citations
10.
Cheng, Yu, Xizi Jiang, Yao Zhang, et al.. (2021). PCGF3 promotes the proliferation and migration of non-small cell lung cancer cells via the PI3K/AKT signaling pathway. Experimental Cell Research. 400(2). 112496–112496. 9 indexed citations
11.
Jiang, Xizi, Yu Cheng, Hongjiu Ren, et al.. (2021). MZT2A promotes NSCLC viability and invasion by increasing Akt phosphorylation via the MOZART2 domain. Cancer Science. 112(6). 2210–2222. 6 indexed citations
12.
Cheng, Yu, Zhi Zhao, Xizi Jiang, et al.. (2021). Ring finger protein 19A is overexpressed in non‐small cell lung cancer and mediates p53 ubiquitin‐degradation to promote cancer growth. Journal of Cellular and Molecular Medicine. 25(16). 7796–7808. 16 indexed citations
13.
Zhang, Bo, Yao Zhang, Xizi Jiang, et al.. (2020). JMJD8 Promotes Malignant Progression of Lung Cancer by Maintaining EGFR Stability and EGFR/PI3K/AKT Pathway Activation. Journal of Cancer. 12(4). 976–987. 14 indexed citations
14.
Jiang, Xizi, Yitong Xu, Hongjiu Ren, et al.. (2020). KLHL18 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by inhibiting PI3K/PD-L1 axis activity. Cell & Bioscience. 10(1). 139–139. 15 indexed citations
15.
Jiang, Xizi, Yitong Xu, Hongjiu Ren, et al.. (2020). Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1. Journal of Cancer. 12(2). 387–396. 24 indexed citations
16.
Jiang, Jun, Hongjiu Ren, Yitong Xu, et al.. (2019). TRIM67 Promotes the Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Positively Regulating the Notch Pathway. Journal of Cancer. 11(5). 1240–1249. 28 indexed citations
17.
Ren, Hongjiu, Yitong Xu, Jun Jiang, et al.. (2019). GRWD1 promotes cell proliferation and migration in non-small cell lung cancer by activating the Notch pathway. Experimental Cell Research. 387(2). 111806–111806. 14 indexed citations
18.
Ren, Hongjiu, Linping Hui, Jun Jiang, et al.. (2019). DRAM2 acts as an oncogene in non-small cell lung cancer and suppresses the expression of p53. Journal of Experimental & Clinical Cancer Research. 38(1). 72–72. 23 indexed citations
19.
Feng, Mingfeng, Xizi Jiang, Shuai Li, et al.. (2018). Identification of Strawberry vein banding virus encoded P6 as an RNA silencing suppressor. Virology. 520. 103–110. 16 indexed citations
20.
Jiang, Jun, Yitong Xu, Hongjiu Ren, et al.. (2018). MKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K/Akt pathway. Journal of Experimental & Clinical Cancer Research. 37(1). 189–189. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026